Literature DB >> 8620935

The amphiphilic properties of novenamines determine their activity as inhibitors of HIV-1 RNase H.

I W Althaus1, K M Franks, K B Langley, F J Kézdy, T Peterson, S E Buxser, D E Decker, L A Dolak, R G Ulrich, F Reusser.   

Abstract

Few inhibitors of the RNase H function associated with the HIV-1 reverse transcriptase have been discovered to date. We observed that three novenamines, U-34445, U-35122, and U-35401, are specific inhibitors of the HIV-1 RT RNase H function. All three compounds are strong amphiphiles and contain one ionizable group. Hence, a priori, in aqueous solutions the inhibitors might exist in at least four different physical states, namely protonated monomers, ionized monomers, protonated micelles, and ionized micelles. The three inhibitors all yielded anomalous dose-response curves, indicating that the four molecular species have different inhibitory potentials. In order to identify the inhibitory species, the amphiphilic properties of these compounds were studied. It was established that in alkaline solutions, around pH 8, all compounds are ionized and form micelles at concentrations above their CMC. Both the protonated and the ionized forms of these molecules form stable insoluble monomolecular layers at the air/water interface. The anomalies of the dose-response curves can be resolved by taking into account the fact that, in solution, the relative proportion of these molecules in each physical state depends on the pH and on their analytical concentration. Thus interpreted, the results indicate that RNase H is inhibited only by the ionized micellar form of these compounds and not by their monomeric form. Around their pKa (approximately pH 5), the three compounds reproducibly form uniformly sized, self-emulsified colloidal particles that may be used as an efficient drug delivery system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8620935     DOI: 10.1007/bf01919535

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  14 in total

1.  Enzymatic kinetic studies with the non-nucleoside HIV reverse transcriptase inhibitor U-9843.

Authors:  I W Althaus; R J LeMay; A J Gonzales; M R Deibel; S K Sharma; F J Kezdy; L Resnick; M E Busso; P A Aristoff; F Reusser
Journal:  Experientia       Date:  1992-12-01

2.  Inhibition of human immunodeficiency virus type 1 RNase H by sulfated polyanions.

Authors:  K Moelling; T Schulze; H Diringer
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

Review 3.  Nonbilayer phases of membrane lipids.

Authors:  M W Tate; E F Eikenberry; D C Turner; E Shyamsunder; S M Gruner
Journal:  Chem Phys Lipids       Date:  1991-03       Impact factor: 3.329

4.  Novenamine is the active moiety in novobiocin.

Authors:  F Reusser; L A Dolak
Journal:  J Antibiot (Tokyo)       Date:  1986-02       Impact factor: 2.649

5.  HP 0.35, a cephalosporin degradation product is a specific inhibitor of lentiviral RNAses H.

Authors:  P Hafkemeyer; K Neftel; R Hobi; A Pfaltz; H Lutz; K Lüthi; F Focher; S Spadari; U Hübscher
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

6.  Inhibition of the RNase H activity of HIV reverse transcriptase by azidothymidylate.

Authors:  C K Tan; R Civil; A M Mian; A G So; K M Downey
Journal:  Biochemistry       Date:  1991-05-21       Impact factor: 3.162

7.  Purification and characterization of an active human immunodeficiency virus type 1 RNase H domain.

Authors:  J S Smith; M J Roth
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  Catalytically distinct conformations of the ribonuclease H of HIV-1 reverse transcriptase by substrate cleavage patterns and inhibition by azidothymidylate and N-ethylmaleimide.

Authors:  X Zhan; C K Tan; W A Scott; A M Mian; K M Downey; A G So
Journal:  Biochemistry       Date:  1994-02-15       Impact factor: 3.162

9.  Inhibition of the reverse transcriptase activity and replication of human immunodeficiency virus type 1 by AS 101 in vitro.

Authors:  A Vonsover; S Loya; B Sredni; M Albeck; T Gotlieb-Stematsky; O Araf; A Hizi
Journal:  AIDS Res Hum Retroviruses       Date:  1992-05       Impact factor: 2.205

10.  Coumarins as inhibitors of bacterial DNA gyrase.

Authors:  I W Althaus; L Dolak; F Reusser
Journal:  J Antibiot (Tokyo)       Date:  1988-03       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.